BANK OF AMERICA CORP /DE/ - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$159
-97.8%
758
-98.3%
0.00%
Q1 2023$7,222
-37.7%
45,136
+116.3%
0.00%
Q4 2022$11,583
-88.2%
20,872
-74.6%
0.00%
Q3 2022$98,000
+48.5%
82,150
-21.7%
0.00%
Q2 2022$66,000
+1000.0%
104,961
+1898.5%
0.00%
Q1 2022$6,000
-88.7%
5,252
-77.7%
0.00%
Q4 2021$53,000
+82.8%
23,595
+178.3%
0.00%
Q3 2021$29,000
-61.3%
8,478
-66.0%
0.00%
Q2 2021$75,000
+31.6%
24,958
+41.6%
0.00%
Q1 2021$57,000
+2750.0%
17,622
+1502.0%
0.00%
Q4 2020$2,0000.0%1,100
-52.5%
0.00%
Q3 2020$2,0000.0%2,316
+10.3%
0.00%
Q2 2020$2,0000.0%2,1000.0%0.00%
Q1 2020$2,0000.0%2,100
-0.2%
0.00%
Q4 2019$2,0000.0%2,104
+8.6%
0.00%
Q3 2019$2,000
-33.3%
1,938
+29.2%
0.00%
Q2 2019$3,0000.0%1,5000.0%0.00%
Q1 2019$3,000
+50.0%
1,5000.0%0.00%
Q4 2018$2,000
-66.7%
1,500
-30.3%
0.00%
Q3 2018$6,000
+100.0%
2,151
+39.5%
0.00%
Q2 2018$3,000
-57.1%
1,542
-51.9%
0.00%
Q1 2018$7,000
-53.3%
3,203
-55.3%
0.00%
Q4 2017$15,000
+7.1%
7,169
-33.4%
0.00%
Q3 2017$14,000
-48.1%
10,759
-38.6%
0.00%
Q2 2017$27,000
-6.9%
17,525
+93.7%
0.00%
Q1 2017$29,000
-75.0%
9,047
-89.5%
0.00%
Q4 2016$116,000
-8.7%
86,306
+6.0%
0.00%
Q3 2016$127,000
+353.6%
81,430
+285.0%
0.00%
Q2 2016$28,000
+7.7%
21,150
+316.5%
0.00%
Q1 2016$26,000
-64.4%
5,078
-45.7%
0.00%
Q4 2015$73,000
+160.7%
9,353
+178.8%
0.00%
Q3 2015$28,000
-96.6%
3,355
-95.5%
0.00%
Q2 2015$825,000
+137.1%
75,306
+202.3%
0.00%
Q1 2015$348,000
-58.6%
24,911
-50.0%
0.00%
Q4 2014$841,000
+106.6%
49,797
+64.0%
0.00%
Q3 2014$407,000
+68.9%
30,357
+60.2%
0.00%
Q2 2014$241,000
+58.6%
18,949
+48.6%
0.00%
Q1 2014$152,000
-72.9%
12,749
-68.6%
0.00%
Q4 2013$561,000
+13.3%
40,592
+42.9%
0.00%
Q3 2013$495,000
-61.6%
28,414
-64.3%
0.00%
Q2 2013$1,289,00079,6400.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders